Together we will beat cancer

Donate

Our milestones: Cisplatin – the story of a platinum-selling life-saver

This entry is part 23 of 30 in the series Our milestones

In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs.

Read More

Cancer survival in England is improving – but still lagging behind similar countries

We explore new data showing that cancer survival in England remains lower than countries with similar healthcare systems.

Read More

Shape-shifting molecular cousins are the key to DNA repair

It’s taken years of frustration and dedication (not to mention countless hours spent in a small room roughly the temperature…

Read More

Cancer killer combination could make cells more sensitive to chemo

How our researchers in Manchester are helping develop ways to make chemotherapy kinder and more effective.

Read More

A disappointing decision over olaparib for ovarian cancer

In light of a preliminary ‘no’ from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug’s development

Read More

New ovarian cancer blood test is promising – but screening still a way off

We look at headlines about a new blood test for ovarian cancer, and why a possible routine screening test for the disease is still some way off.

Read More

Unpicking the genetic ‘patchwork’ in ovarian cancer

Our researchers are investigating the genetic ‘patchwork’ underlying ovarian tumours, which will lead to more effective treatments in the future.

Read More

Lethal Weapon Too: Using DNA repair processes to target cancer

A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes.

Read More

Coming ever closer – first PARP inhibitor licensed in Europe

Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?

Read More

A year of research – and 13 milestones you helped fund

To coincide with the publication of our Annual Review, here are some of the key research milestones that our amazing supporters have helped fund.

Read More